Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

A new study suggests that a pill used for emergency contraception could be repurposed at a higher dose as an abortion drug, providing a possible alternative to mifepristone, one of the two drugs ...

Jan. 15, 2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for ...

Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo Abbott Laboratories on ...

Jan. 21, 2025 — When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as ...

Reports that Novartis was in advanced negotiations over a bid for Cytokinetics emerged early last week as the JP Morgan Healthcare conference got underway, but by the end of the week there was no ...

Alda Mizaku says the health system also is using artificial intelligence to boost predictive analytics efforts, among other use cases. And she offers advice to peers looking to become healthcare Chief ...

Cytokinetics has been a top biotech takeover candidate for some time, thanks to blockbuster speculation about its lead drug aficamten, but a $1 billion-plus set of financing deals shows it is ...

A new study led by University of Arizona Mel and Enid Zuckerman College of Public Health researchers in collaboration with fire service partners and other researchers around the country through ...

Celiac artery compression syndrome, also known as median arcuate ligament syndrome, is a condition where a muscular fibrous band of the diaphragm, the median arcuate ligament, compresses the celiac ...

Sino Biopharmaceutical CEO Eric Tse discusses the outlook of the company, Asian pharmaceutical markets, and the potential impacts from US President Donald Trump's tariffs and policy. Tse speaks to ...